Percheron Targets $15 Billion for New Fund a Year After First 🍑 Chiratae Ventures Growth Fund I announces its first close at

Chiratae Ventures marks final close of maiden growth fund at

Brookfield Seeks Up to $15 Billion for Private Equity Fund

Goldman Sachs Raises Over $15 Billion for Secondary Private

Pfizer BioNTech Boost Vaccine Output Goal by More Than 50%

GIP Targets $25 Billion for Record Infrastructure Fund

KKR closes $15 billion fund targeting consumption and

After Investing More Than $1 Trillion In 2024 Forbes

Chiratae Ventures Growth Fund1 makes first close of Rs 759 Cr

Highlights of budget 2024 Billions for green economic growth

Percheron closes debut fund at $770m Alternatives Watch

Percheron Targets $15 Billion for New Fund a Year After First

GIP amasses up to $15bn for Fund V as it eyes yearend close

Pfizer targets at least 2 billion COVID19 vaccine doses this


2 févr. 2024 · Feb 2 (Reuters) - Pfizer Inc (PFE.N) said on Tuesday it expects to generate $15 billion, or about a quarter of its total revenue this year, from sales of its COVID-19 vaccine co-developed. 10 déc. 2024 · Pfizer has manufactured 3 billion doses in 2024 and plans to manufacture up to 4 billion doses in 2024 worldwide. The company has pledged to provide 2 billion doses to low- and middle-income countries (LMICs) during that period – 1 billion in 2024 and 1 billion in 2024. To accelerate efforts to reach vulnerable populations, we have pledged to provide 2 billion doses of our COVID-19 vaccine to low- and middle-income countries in 2024 and 2024 – at least 1 billion doses each year. Pfizer-BioNTech COVID-19 vaccine doses arrive in Kigali, Rwanda. 2 févr. 2024 · Pfizer Inc said on Tuesday it expects to generate $15 billion, or about a quarter of its total revenue this year, from sales of its COVID-19 vaccine co-developed with German partner BioNTech SE. Pfizer aims to make two billion doses of the COVID-19 vaccine in 2024. Pfizer Chief Executive Albert Bourla said in an interview that the. 11 janv. 2024 · The German vaccine maker BioNTech and US pharmaceutical giant Pfizer said they could produce up to 2 billion doses of their coronavirus vaccine in 2024,according to documents released. 11 janv. 2024 · Pfizer Inc. and BioNTech SE plan to produce 2 billion doses of their Covid-19 vaccine this year, boosting previously expected output by more than 50% in response to surging global.